Rosetta Genomics Enters Collaboration With Clalit Health Services' Rabin ... MarketWatch About Chronic Allograft Dysfunction Kidney transplantation is widely accepted as the treatment of choice for end-stage renal disease. The number of patients receiving renal replacement therapy worldwide is estimated at more than 1.4 million and is ... |
